Adjuvant Therapy with Pembrolizumab in Renal Cell Carcinoma: Real-World Experiences from a Retrospective, Multi-Institutional Cohort
Recurrence rates in the M1NED group remained high and occurred earlier in our real-world compared to KEYNOTE-564. Long-term toxicities were comparable to clinical trials data.
Authors
- Alexander Cox (ORCID: https://orcid.org/0000-0001-7837-5740)
- Charis Kalogirou (ORCID: https://orcid.org/0000-0003-3802-940X)
- Friedemann Zengerling (ORCID: https://orcid.org/0000-0002-6150-2675)
- Kerstin Junker (ORCID: https://orcid.org/0000-0002-0873-8128)
- Luka Flegar (ORCID: https://orcid.org/0000-0002-1477-9161)
- Jörg Ellinger (ORCID: https://orcid.org/0000-0002-7526-0857)
- Philipp Schmucker (ORCID: https://orcid.org/0000-0002-3487-0560)
- Séverine Banek
- Philip Zeuschner (ORCID: https://orcid.org/0000-0001-8898-6588)
- Angelika Mattigk (ORCID: https://orcid.org/0000-0001-8710-458X)
- Cristina Cano Garcia (ORCID: https://orcid.org/0000-0002-4829-0241)
- Oliver Hahn (ORCID: https://orcid.org/0000-0002-8864-2491)
- Niklas Klümper (ORCID: https://orcid.org/0000-0002-3258-0586)
- Johannes Huber (ORCID: https://orcid.org/0000-0001-7243-8958)
- Bjoern Thorben Buerk
- Benedikt Hoeh (ORCID: https://orcid.org/0000-0002-4238-6584)
- Kati Erdmann (ORCID: https://orcid.org/0000-0003-3717-3637)
Institutions
- Goethe University Frankfurt (DE)
- Philipps University of Marburg (DE)
- University of Würzburg (DE)
- University Hospital Bonn (DE)
- University Medical Center Freiburg (DE)
- University Hospital Frankfurt (DE)
- University Hospital Ulm (DE)
- University Hospital Carl Gustav Carus (DE)
- Technische Universität Dresden (DE)
- Saarland University (DE)
Publication Details
- Journal
- Urologia Internationalis
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1159/000543278
- Citations
- 4
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.68